Indication

Klebsiella joint infection

A Klebsiella joint infection is a form of septic arthritis characterized by bacterial invasion and inflammation of the synovial fluid and articular tissues by species of the Gram-negative bacillus genus *Klebsiella*, most commonly *Klebsiella pneumoniae*. Read more about Klebsiella joint infection

54 drugs 32 manufacturers

Advertisement

Drugs that treat it

Common Klebsiella joint infection therapies.

Showing 19–27 of 54 drugs

Filter & compare in the drug finder →Opens the drug finder with Klebsiella joint infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Klebsiella joint infection.

A Klebsiella joint infection is a form of septic arthritis characterized by bacterial invasion and inflammation of the synovial fluid and articular tissues by species of the Gram-negative bacillus genus *Klebsiella*, most commonly *Klebsiella pneumoniae*.

It typically affects large weight-bearing joints—such as the knee or hip—and predominantly occurs in neonates, elderly individuals, or patients with underlying risk factors like diabetes mellitus, immunosuppression, cirrhosis, or recent bacteremia.

Pathophysiologically, hematogenous seeding or direct inoculation leads to rapid purulent effusion, leukocytic infiltration, and the release of proteolytic enzymes that can cause rapid cartilage destruction and permanent functional loss if untreated.

Clinically, it manifests as acute, severe joint pain, swelling, erythema, warmth, and marked limitation of range of motion, often accompanied by systemic fever.

Personalize your experience

Follow Klebsiella joint infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it